Form D · Other Technology

Healigo Inc.

Boston, MA · CIK 0001648667

Offering snapshot reported Jan 4, 2017 · SEC filing

Reported sold
$303K
Offering amount: $500K
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 10, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$152K$303KJul 23, 2015: $45,000.00Jul 23, 2015Mar 15, 2016: $258,000.00Mar 15, 2016Apr 29, 2016: $273,000.00Jan 4, 2017: $303,000.00Jan 4, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$273,000 → $303,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 4, 2017Amendment$303,000$30,000vs Apr 29, 201621SEC filing
Apr 29, 2016Amendment$273,000$15,000vs Mar 15, 201621SEC filing
Mar 15, 2016Amendment$258,000$213,000vs Jul 23, 201521SEC filing
Jul 23, 2015Initial$45,000No comparison2SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-244298

Source: Form D, filed Jan 4, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nicholas P. Fontana Director, Executive
David T. Lemione Director, Executive
Jonathan Mc Kenzie Director
Lauren Ripley Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
18 Cooper St. Unit 5
Boston, MA, 02113